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Edited by Lev KisselevAbstract Eukaryotic initiation factor 6 (eIF6, alias p27BBP) is
required for the biogenesis of 60S ribosomal subunits. eIF6
expression levels are tightly regulated in vivo, where they corre-
late with cellular growth. We analyzed how transcriptional
regulation of eIF6 is achieved. We show that the human eIF6
promoter contains consensus sites for the GABP (GA-binding
protein) transcription factor complex. Functional analysis of
GABP consensus sequences by point mutations, EMSA (electro-
phoretic mobility shift assay) and a dominant negative mutant
indicates that GABP is essential for eIF6 promoter activity.
These data strengthen the hypothesis that GABP is a global
regulator of ribosome synthesis.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Ribosome biogenesis is the process by which ribosomes are
generated and exported to the cytoplasm where they are re-
cruited for translation by initiation factors. Ribosome biogen-
esis accounts for up to half of the transcriptional activity of
cycling cells [1]. Brieﬂy, it requires the synthesis and processing
of rRNA which is then assembled into mature ribosomes to-
gether with structural ribosomal proteins. Several non-struc-
tural ribosomal proteins (trans-acting factors) are also
required for the biogenesis of functional ribosomes. These
trans-acting factors transiently associate with dynamic pre-
ribosomal particles and comprise enzymes critical for rRNA
processing, chaperones for ribosome transport and factors of
undeﬁned function [2,3]. Most trans-acting factors in ribo-
somal biogenesis are required for assembly of ribosomes.*Corresponding author. Fax: +39 0226434855.
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doi:10.1016/j.febslet.2006.02.068We identiﬁed eIF6 (alias p27BBP, b4 binding protein) by its
ability to bind b4 Integrin [4]. However, eIF6 is present in
the nucleolus of all cells. Data show that eIF6 is a necessary
transacting factor for the biogenesis of eukaryotic 60S ribo-
somal subunits [5–7]. In addition, eIF6 escorts 60S subunit
from the nucleus to the cytoplasm; eIF6 release from 60S sub-
unit is necessary for the initiation of translation both in mam-
malian [8] and in yeast cells [9].
Levels of eIF6 mRNA and protein are variable among tis-
sues [10], and even within the same tissues, diﬀerent cells
have diﬀerent levels of the protein [10,11]. Several data indi-
cate that regulation of eIF6 is relevant to tissue homeostasis
and cell growth: in cancer tissues, eIF6 mRNA and protein
are upregulated and predict malignancy [11,12]; in skin,
upregulation of eIF6 is sharp during rupture of the epider-
mal barrier [13]; mast cell activation is accompanied by a
several-fold increase of eIF6 expression [14]. In general,
eIF6 protein levels match mRNA levels [11,14], whereas
eIF6 biochemical activity is regulated by phosphorylation
[8,15]. The essential role of eIF6 in ribosome biogenesis,
and the observation that eIF6 mRNA levels vary among dif-
ferent cells, prompted us to study its transcriptional regula-
tion. Here we show that the eIF6 promoter is strongly
controlled by the GABP complex.2. Materials and methods
2.1. Plasmids
To clone the human ITGB4BP [16] promoter (Supplementary Fig-
ure 1; gi|51511747|) into pGL3-basic vector (Promega), a fragment
from 1258-bp upstream of the transcription start to the ATG was
ampliﬁed with Pwo from genomic DNA with oligonucleotides sense
(U1) GAGTGTCTCTTGAAGTACA and antisense (D1)
GGACCGCCATGAGGCC. The resulting fragment was the 1258/
+98 construct. This construct was then used to generate the two con-
structs 1258/674 and 674/+98 which were subcloned, respectively,
into pGL3 promoter vector (Promega) and pGL3 basic vector. The oli-
gonucleotides used for the construct 1258/674 were sense U1 and
antisense D2 (GAGTGCTGACGAATGAGA). For the construct
674/+98 we used sense U2 (ATCTCATTCGTCAGCACTC) and
antisense D1. Deletion regions encompassing the promoter region
from 674 to +98 gene were subcloned in the KpnI and BglII sites
of pGL3 basic. The oligonucleotides used are summarized in Table
1. All plasmids were veriﬁed by DNA sequencing. The GABP muta-
tion was generated in the 674/+98 plasmid with the QuickChange













Fig. 1. The674/230 region of ITGB4BP promoter contains most of
its activity in cycling cells and in G1. (A) Luciferase activity of the
ITGB4BP promoter. All constructs were cloned in luciferase reporter
plasmid pGL3, and normalized to co-transfected TK-Renilla. (B) The
1258/674 region is a weak enhancer. The region was cloned in
pGL3 plasmid containing SV40 promoter (pGL3*) and tested. (C) The
ITGB4BP promoter is more active in G1 phase. Cells were transfected
with either the 674 construct (grey) or with the 230 (black) and
pulsed with various drugs to enrich for deﬁned cell cycle phases. G1
cells were 58% for mimosine (G1), 28% for colchicine (G2/M), and
between 41% and 45% for the other two treatments. S.D. less than 5%.
**P 6 0.01.
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The resulting plasmid presents TT instead of GG at 240/239 and
225/224 of the sequence. The dominant negative dnGABPa and -
b expression plasmids were provided by Dr. M. Sunesen (Pasteur Insti-
tute) and are described in [17]. Brieﬂy, they consist in a fusion CFP in
frame with truncated GABPs.
2.2. Luciferase assay
HeLa cells, (2.5 · 105 cells) maintained in Dulbecco’s modiﬁed
Eagle’s medium with 10% fetal bovine serum, were seeded into six-
well plates the day before transfection. The next day cells were
transfected using a calcium phosphate standard protocol [18]. To
normalize for transfection eﬃciency, the pRL-TK expression plasmid
(Promega) containing Renilla luciferase was co-transfected. Lucifer-
ase activity was measured by the Dual-Luciferase Reporter Assay
System (Promega) according to the manufacturer’s instructions.
Transfections were performed in triplicate and repeated at least three
times.
The dnGABPa and -b expression plasmids (3 lg) were co-transfec-
ted with the promoter plasmid (1.5 lg) using GenePORTER. Cells
were lysed after 48 h. Luciferase activity assays were performed as
above.
2.3. Drug treatments
For cell cycle experiments, HeLa cells were co-transfected with
674/+98 plasmid and pRLTK as above. Immediately after transfec-
tion, cells were treated either with mimosine (ﬁnal concentration
400 lM) or thymidine (ﬁnal, 2 mM) for 16 h to enrich in late G1-phase
and S1-phase, respectively, or with colchicine (ﬁnal, 10 lM) for 4 h to
block in G2/M-phase. Serum starvation was performed for 24 h to
block in G0-phase. The cells were harvested at 44 h for luciferase assay
and FACS analysis.
2.4. EMSA
Collected HeLa cells were washed with PBS, resuspended in buﬀer
A (20 mM HEPES, pH 7.8, 1 mM MgCl2, 0.5 mM CaCl2, 1 mM
dithiothreitol and 1 mM phenylmethylsulfonyl ﬂuoride) and incu-
bated on ice for 10 min. After homogenization, the cells were centri-
fuged at 2000 rpm for 10 min, resuspended in 1 ml of extraction
buﬀer (100 mM Tris–HCl, pH 7.9, 420 mM NaCl , 5 mM MgCl2,
1 mM EDTA, 5% glycerol, 1 mM dithiothreitol and 0.5 mM phenyl-
methylsulfonyl ﬂuoride) and incubated on ice for 30 min. The nucle-
ar extracts were dialyzed against 100 ml of buﬀer B (20 mM
HEPES, pH 7.8, 100 mM KCl, 0.2 mM EDTA, 20% glycerol,
1 mM dithiothreitol and 0.5 mM phenylmethylsulfonyl ﬂuoride)
for 5 h at 4 C. EMSAs were performed by using double-stranded
oligonucleotide probes labeled with [c32P]dATP by T4 Polynucleo-
tide Kinase. The probe (5 fmol) was incubated for 20 min at room
temperature in 20 ll of binding buﬀer (20 mM HEPES, pH 7.9,
0.2 mM EDTA, 20% glycerol, 1 mM dithiothreitol and 0.5 mM
phenylmethylsulfonyl ﬂuoride and 2 lg of poly (dI-dC) containing
5 lg of nuclear extract. Oligonucleotide competition experiments
were performed with the indicated amount of unlabeled oligonucle-
otides. For supershift experiments, 2 lg of antibodies against
GABP-a and GABP-b Santa Cruz Biotechnology) were added to
the mixture 30 min prior to the addition of labeled probe, and fur-
ther incubated for 20 min at room temperature. The protein–DNA
complexes were separated on 6% non-denaturing polyacrylamide
gels and subjected to autoradiography.2.5. Immunoﬂuorescence
HeLa cells transfected with dnGABPs were ﬁxed 24 h after transfec-
tion, permeabilized and incubated with rabbit anti-p27BBP (eIF6) pri-
mary antibody as previously described [4,5]. Subsequently, cells were
incubated for 30 min with TRITC-conjugated goat anti-rabbit second-
ary antibody (Southern Biotechnology Associates Inc.) and FITC-con-
jugated phalloidin (Sigma–Aldrich) to identify ﬁlamentous actin.
ECFP/dnGABP fusion was visualized at 432 nm.3. Results and discussion
Nomenclature for the gene encoding eIF6 is ITGB4BP [16].
We will refer for simplicity to either ITGB4BP or to eIF6 pro-
tein. The main transcription start of ITGB4BP promoter is 98
nucleotides upstream to the ATG [10,19]. In order to study the
promoter activity of ITGB4BP gene, upstream regions from
the main transcription start site were cloned in the promoter-
less luciferase reporter pGL3-basic. Resulting plasmids
1258/+98 and 674/+98, showed 60-fold and 50-fold
luciferase activity higher than the control promoterless plas-
mid. The 230/+98 promoter had a residual 5-fold promoter
activity (Fig. 1A). We evaluated the strength of enhancers in
the region between 1258 and 674 by fusing this segment
Fig. 3. GABP complex regulates the ITGB4BP promoter. (A) Muta-
tion of the GABP consensus sequence (see text) in the core region of
the ITGB4BP promoter strongly reduces its activity. (B) Co-transfec-
tion of the core ITGB4BP promoter with either dominant negative
GABPa or GABPb strongly reduces its activity. Wild-type promoter in
A and B was, arbitrarily, set to 100.
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Comparison of the activity of the 1258/675 region to the
pGL3- promoter plasmid revealed that this fragment is a very
weak enhancer (Fig. 1B). Thus, the 5 0-ﬂanking sequence from
674 to 200 controls most of ITGB4BP expression.
The biogenesis of ribosomes in cultured cells is higher in G1.
We wanted to deﬁne whether the ITGB4BP promoter had a
cell-cycle dependent activity. The promoter region between
230 and +98, which had only a basal activity was chosen
as an internal control. Cells were transfected with either the
674/+98 construct or with the 230/+98 one, and treated
with mimosine and thymidine to enrich in late G1-phase and
S1-phase respectively, or colchicine to block in G2/Mphase.
Cell cycle staging was determined by FACS analysis (see leg-
end). The 674 bp promoter showed higher activity in cells
at late G1 phase, and lower at mitosis (Fig. 1C). Thus, this re-
gion of the promoter confers both basal and cell-cycle regu-
lated expression to the ITGB4BP gene.
To deﬁne cis elements in the 674/200 region which might
be important in ITGB4BP regulation, we performed a stan-
dard deletion analysis (Fig. 2). The results indicated a modular
promoter with regulatory sites from 674 to 356 and a
highly active region from 356 to 210. Deletion of sequence
between 674 and 455 reduced promoter activity, which was
restored by deletion of region 445/356. These data sug-
gested the presence of negative regulatory elements in this up-
stream region. More importantly, promoter activity was
almost abolished by deleting the sequence between 319 and
203. In summary, data in Fig. 2 suggest that the sequence be-
tween 319 and 203 bp of the human ITGB4BP promoter
contains one or more strong positive critical regulatory ele-
ments. To identify these regulators, we screened for putative
transcriptional targets.
The human genomic sequence of the ITGB4BP promoter
region (Supplementary Figure 1) contains IRF-1 and -2 (inter-
feron regulatory factors) and GABP (or EFT4) binding sites.
Thus, we analyzed these two targets by mutational analysis.
Site-directed mutagenesis of IRF-1/2 binding domains in the
674/+98 ITGB4BP promoter construct did not aﬀect its
activity in cycling HeLa and HaCat cells and was not further
studied (not shown). In contrast, site-directed mutagenesis of
GABP binding sites had a strong eﬀect and is hereafter
described. Schematically, GABP is an ETS transcription factorFig. 2. Deletion analysis of ITGB4BP promoter underscores modulatory re
**P 6 0.01; *P 6 0.05, two-tailed T-test.composed of a and b subunit [20–22]. GABPa contains the
DNA binding domain and interacts with GABPb to form an
active dimeric complex on a single GABP consensus motif
(CGGAAR). A tetrameric complex, composed of two GABPa
and two GABPb subunits can be formed when two GABP
binding sites are present [21]. Mutation by site-directed muta-
genesis of the two GABP binding sites present in the ITGB4BP
promoter caused a reduction of luciferase activity of 60%
(Fig. 3A).
We then asked whether blocking endogenous GABP activity
had the same eﬀects on ITGB4BP promoter as mutation of
GABP sites. We co-transfected plasmids encoding dominant
negative mutants of either GABPa or GABPb with the
674/+98 construct. Fig. 3B shows that both dnGABP expres-
sion plasmids inhibited ITGB4BP promoter activity.
Next, we performed mobility gel-shift assay. Incubation of
nuclear extracts with a labelled synthetic DNA oligomer con-
taining both GABP consensus sites resulted in formation of
one fast complex representing the GABPa subunit, and two
major complexes representing respectively the GABPa2b2 tet-
ramers and the GABPab dimers (Fig. 4, lane 4). The com-
plexes GABPa2b2 and GABPab were reduced and abolished
by dose-dependent competition with 100-, 250- or 500-fold ex-
cess of unlabeled wild-type probe (Fig. 4, lanes 1–3). Competi-
tion with single mutated oligonucleotides M1 and M2 resulted,
as expected, in the total loss of GABPa2b2 signal and reduc-
tion of GABPab dimer signal (lanes 5 and 6). In agreement
with the previous experiments, the single mutated M1 oligonu-
cleotide generated in the EMSA a signal compatible with agions and an highly active core. Experiments performed as in Fig. 1.
Fig. 4. EMSA shows the binding of GABPa2b2 tetramers and GABP ab dimers to ITGB4BP. (A) Sequence of ITGB4BP promoter, the wt oligo
with two GABP consensus sites, and the single mutated oligos M1 and M2. Left panel, lane 4 shows GABP dimer and tetramer complexes formed by
incubating nuclear extracts with wt oligo; inhibition of binding is observed using either wt or single mutated oligos (lanes 1–3 and 5–6); middle panel,
lane 7 shows the expected dimer formation on M1 sequence, as compared to tetramer, on wt sequence in lane 9; right panel, supershift of GABP
complex by incubation with anti-GABPa antibodies (lane 12).
Fig. 5. dnGABP aﬀects nucleolar size. HeLa cells transfected with
dnGABPb stained for actin (green), eIF6 (red) and dnGABP (cyano).
The ﬁeld shows also a non-transfected cell with three nucleoli indicated
by an arrow. Three nucleoli from two dnGABP transfected cells (note
the nuclear cyano staining of dnGABP) are also indicated by the white
arrowhead. This typical image shows that cells expressing dnGABP
have less nucleolar eIF6 in comparison to not transfected cells. The
dnGABP is in the nucleus (n). Scale bar is 6 lM.
1986 A. Donadini et al. / FEBS Letters 580 (2006) 1983–1987GABPab dimer, displaced by competition with cold oligonu-
cleotide (lanes 7 and 8). Similar results were observed with
the single mutated M2 oligonucleotide (not shown). Finally,
the complexes formed with wild-type GABP were supershifted
by GABPa antibodies (compare lane 12 to lane 10).
eIF6, the product of ITGB4BP gene, is essential in ribosome
biogenesis. We reasoned that if GABP controls its expression it
may regulate ribosome biogenesis. An estimation of ribosome
activity can be inferred by nucleolar size. Thus, we transfected
dnGABP on HeLA cells and we simultaneously evaluated ac-
tin cytoskeleton -green-, GAPB expression -cyano- and nucle-
olar staining of eIF6. Interestingly, cells with transfected
dnGABP had an altered and reduced nucleolar staining of
endogenous eIF6 (Fig. 5).
By a combination of mutational analysis and transfection
with dn-GABP proteins, we show that GABP regulates eIF6
promoter. The observation that a conspicuous amount of tran-
scriptional activity of eIF6 promoter is regulated by GABP
complex is interesting in view of the function of eIF6. Bio-
chemical data place eIF6 in pre-ribosomal complexes that
are intermediates of 60S biogenesis [2,23]. In the past, consis-
tent evidence has shown that several structural ribosomal pro-
teins are also a signiﬁcant target of GABP complex (reviewed
in [24]). Taken together these observation strongly enforce the
A. Donadini et al. / FEBS Letters 580 (2006) 1983–1987 1987idea that GABP is a global regulator of ribosome biogenesis,
hence cell growth. Indeed, GABP is an essential transcription
factor, and knockout mice of GABP do not survive beyond
implantation, suggesting a role in essential cellular process
[25]. In addition, cells with impaired but not null GABP activ-
ity are highly impaired in growth [26]. Another class of pro-
teins regulated by GABP complex is represented by
mitochondrial enzymes such as cytoC (reviewed in [27]). Thus,
an attractive speculation, to be further explored, is that the
activity of GABP complex coordinates two processes abso-
lutely required for cell growth in mammalian cells, such as res-
piration and ribosome synthesis.
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